T43.0X2D Poisoning by tricyclic and tetracyclic antidepressants, intentional self-harm, subsequent encounter

Name of the Condition

• Poisoning by tricyclic and tetracyclic antidepressants, intentional self-harm, subsequent encounter
• Technical term: T43.0X2D

Summary

This code describes an intentional self-harm poisoning by tricyclic or tetracyclic antidepressants during a subsequent encounter. It applies when clinical documentation confirms the poisoning was intentional and the patient is receiving follow-up care for the event. Tricyclic and tetracyclic antidepressants are used to treat depression and other mental health conditions, and this code is specific to intentional overdoses in a subsequent care setting.

Causes

Intentional poisoning may result from deliberate overdose of the medication, often associated with suicidal ideation or self-harm behaviors. The subsequent encounter indicates the patient is receiving ongoing care after the initial poisoning event, which may include monitoring, therapy, or rehabilitation.

Risk Factors

• History of depression, anxiety, or other mental health conditions that increase self-harm risk.
• Prior suicide attempts or suicidal ideation.
• Concurrent use of other substances that exacerbate overdose effects.
• Lack of social support or access to mental health resources.
• Recent life stressors or crises that may trigger self-harm.

Symptoms

• Drowsiness, confusion, or altered mental status.
• Rapid heart rate, irregular heartbeat, or low blood pressure.
• Seizures, tremors, or muscle rigidity.
• Nausea, vomiting, or abdominal pain.
• Dry mouth, blurred vision, or urinary retention.
• Respiratory depression or coma in severe cases.

Diagnosis

Diagnosis relies on clinical documentation confirming intentional self-harm and a subsequent encounter. Healthcare providers assess symptoms, medication history, and intent. Laboratory tests (e.g., drug levels, toxicology screens) may support the diagnosis, but the code requires explicit documentation of intent and follow-up care.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing underlying mental health needs. This may include activated charcoal, supportive care (e.g., airway management), cardiac monitoring, and psychiatric evaluation. Long-term care often involves therapy, medication management, and safety planning.

Prognosis and Follow-Up

Prognosis depends on the severity of the poisoning and timely intervention. Subsequent encounters involve monitoring for complications, adjusting mental health treatment, and ensuring patient safety. Follow-up care is critical to prevent recurrence and support recovery.

Complications

• Cardiac arrhythmias or heart failure.
• Seizures or neurological damage.
• Respiratory failure or aspiration.
• Kidney or liver injury.
• Worsening mental health or recurrent self-harm.

Lifestyle & Prevention

• Secure medications to prevent access.
• Follow prescribed dosing and avoid abrupt changes.
• Engage in regular mental health check-ins.
• Build a support network and crisis plan.
• Avoid alcohol or other drugs that interact with antidepressants.

When to Seek Professional Help

Seek immediate care for suspected overdose or self-harm. Contact emergency services if symptoms include severe drowsiness, seizures, or difficulty breathing. Follow up with mental health providers for ongoing support.

Tips for Medical Coders

Document intent (intentional self-harm) and encounter type (subsequent) clearly. Ensure the code aligns with clinical notes specifying follow-up care after the initial poisoning event. Verify that tricyclic or tetracyclic antidepressants are the causative agent.